MARKET

BNGO

BNGO

Bionano Genomics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.515
-0.005
-0.33%
Opening 13:09 07/06 EDT
OPEN
1.490
PREV CLOSE
1.520
HIGH
1.580
LOW
1.490
VOLUME
2.96M
TURNOVER
2.80M
52 WEEK HIGH
6.88
52 WEEK LOW
1.160
MARKET CAP
438.89M
P/E (TTM)
-4.6260
1D
5D
1M
3M
1Y
5Y
Bionano gets US patent for analysis of nucleic acid fragments for genetic abnormalities
Bionano Genomics (NASDAQ:BNGO) <a href="https://seekingalp...
Seekingalpha · 06/29 13:08
Bionano Genomics Announces Issuance Of A U.S. Patent For Analysis Of Small Nucleic Acid Fragments In Nanochannel Arrays
Bionano Genomics, Inc. (NASDAQ:BNGO), today announced that the United States Patent and Trademark Office issued US Patent No.11,359,244 on June 14, 2022. The patent, titled "CHARACTERIZATION OF
Benzinga · 06/29 12:20
Bionano Genomics Announces Issuance of a U.S. Patent for Analysis of Small Nucleic Acid Fragments in Nanochannel Arrays
SAN DIEGO, June 29, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that the United States Patent and Trademark Office issued US Patent No.11,359,244 on June 14, 2022. The patent, titled “CHARACTERIZATION OF MOLECULES IN NAN...
GlobeNewswire · 06/29 12:00
JD, LI and XPEV among pre markets gainer
Revlon REV +78% spikes as Indian conglomerate reportedly eyes buyout. Blackboxstocks (BLBX) +21%. Kazia Therapeutics (KZIA) +14% as US FDA awards orphan drug designation to Paxalisib for AT/RT. Alibaba Group Holding BABA +10% on report
Seekingalpha · 06/17 12:32
Bionano Genomics Announces Participation at the European Association for Cancer Research (EACR) Congress 2022 Featuring OGM Applications for Cancer Research
Bionano will exhibit its solutions relevant to cancer research: the Saphyr® system, NxClinical™ software and expert laboratory servicesA corporate satellite presentation by Alicia Bertolotti, Bionano, Dr. Sylvia Genovese, Bambino Gesù Children’s Hospital, ...
GlobeNewswire · 06/16 12:00
Bionano Genomics Announces Participation at the European Society of Human Genetics Conference (ESHG) 2022 Featuring OGM Across a Broad Range of Clinical Research Applications and a Collaborative Product Development with Hamilton
The Long String VANTAGE for DNA isolation, a collaborative development between Bionano and Hamilton, and the world’s first automation solution for Ultra High Molecular Weight (UHMW) extraction used in optical genome mapping (OGM), will be on display at the...
GlobeNewswire · 06/10 12:00
Hamilton And Bionano Genomics Announce Ultra High Molecular Weight DNA Extraction Automation Solution For OGM
Hamilton and Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the collaborative development of the Long String VANTAGE for the isolation of Ultra High Molecular Weight (UHMW) DNA for use in optical genome
Benzinga · 06/09 13:05
Hamilton and Bionano Genomics Announce World’s First Ultra High Molecular Weight DNA Extraction Automation Solution for OGM
Automated UHMW DNA extraction can consistently yield ultra-long DNA of outstanding quality and at increased throughput without user interventionSAN DIEGO, June 09, 2022 (GLOBE NEWSWIRE) -- Hamilton and Bionano Genomics, Inc. (Nasdaq: BNGO) today announced ...
GlobeNewswire · 06/09 13:00
More
No Data
Learn about the latest financial forecast of BNGO. Analyze the recent business situations of Bionano Genomics Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

66.67%Strong Buy
33.33%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BNGO stock price target is 8.67 with a high estimate of 12.00 and a low estimate of 6.00.
High12.00
Average8.67
Low6.00
Current 1.540
EPS
Actual
Estimate
-0.09-0.07-0.04-0.02
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 164
Institutional Holdings: 73.29M
% Owned: 25.30%
Shares Outstanding: 289.70M
TypeInstitutionsShares
Increased
47
4.23M
New
19
1.67M
Decreased
52
5.87M
Sold Out
25
3.36M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.15%
Healthcare Equipment & Supplies
+0.50%
Key Executives
Non-Executive Chairman/Independent Director
David Barker
President/Chief Executive Officer/Director
R. Erik Holmlin
Chief Financial Officer
Christopher Stewart
Chief Operating Officer
Mark Oldakowski
Chief Human Resource Officer
Helene Klein
Other
Alka Chaubey
Other
Soheil Shams
Other
Richard Shippy
Independent Director
Yvonne Linney
Independent Director
Albert Luderer
Independent Director
Hannah Mamuszka
Independent Director
Aleksandar Rajkovic
Independent Director
Christopher Twomey
Independent Director
Kristiina Vuori
Independent Director
Vincent Wong
No Data
No Data
About BNGO
Bionano Genomics, Inc. is focused on providing optical genome mapping, solutions for genome analysis. The Company provides tools and services based primarily on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. It also provides diagnostic testing services for pediatric patients suspected of neurodevelopmental disabilities. Its Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to search for diagnostics and therapeutic targets and to streamline the identification of structural changes in chromosomes. The Saphyr system is consists of an instrument, chip consumables, reagents, and a suite of data analysis tools. It also provides proprietary molecular genetic diagnostic services for individuals demonstrating clinical presentations consistent with neurodevelopmental disorders, including autism spectrum disorders and other disorders of childhood development.

Webull offers kinds of BioNano Genomics Inc stock information, including NASDAQ:BNGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNGO stock methods without spending real money on the virtual paper trading platform.